Investor

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North

Analyst Coverage

ABG Sundal Collier

Research initiated on 19 November 2021

Kapital Partner

Research initiated on 10 November 2021

Kapital Partner web site is: here

Redeye

Research (commissioned) initiated on 11 October 2021.

Redeye corporate page on FluoGuide is here

SEB

Research (commissioned) initiated on 30 November 2020.

SEB’s corporate page on FluoGuide is here.